Glycoconjugate Vaccines for Prevention of Haemophilus influenzae Type b Diseases

This review summarizes the experience in laboratory- and industrial-scale syntheses of glycoconjugate vaccines used for prevention of infectious diseases caused by Haemophilus influenzae type b bacteria based on the linear capsular polysaccharide poly-3-β-D-ribosyl-(1→1)-D-ribitol-5-phosphate (PRP)...

Descripción completa

Detalles Bibliográficos
Autores principales: Khatuntseva, E. A., Nifantiev, N. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pleiades Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980804/
https://www.ncbi.nlm.nih.gov/pubmed/33776394
http://dx.doi.org/10.1134/S1068162021010106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980804/
https://www.ncbi.nlm.nih.gov/pubmed/33776394
http://dx.doi.org/10.1134/S1068162021010106

Ejemplares similares